Oramed Pharmaceuticals (ORMP) Shares Outstanding (2011 - 2026)

Oramed Pharmaceuticals (ORMP) has 16 years of Shares Outstanding (Entity) data on file, last reported at $40.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.18% year-over-year to $40.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.9 million (changed 0.18% YoY) and the FY2025 annual result came in at $39.3 million, down 1.62% from the prior year.
• Shares Outstanding (Entity) improved to $40.9 million in Q1 2026, from $39.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $40.9 million in Q1 2026 to a low of $38.7 million in Q1 2022.
• A 5-year average of $40.0 million and a median of $40.2 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) gained 3.69% — and 2025, when it declined 1.62%.
• Tracing ORMP's Shares Outstanding (Entity) over 5 years: stood at $39.0 million in 2022, then increased by 3.44% to $40.3 million in 2023, then decreased by 1.04% to $39.9 million in 2024, then decreased by 1.62% to $39.3 million in 2025, then rose by 4.2% to $40.9 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $40.9 million (Q1 2026), $39.3 million (Q4 2025), and $40.8 million (Q3 2025), per Business Quant data.